Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
J Pediatr ; 269: 114004, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38447756

ABSTRACT

OBJECTIVE: To examine clinical correlates and prevalence of food selectivity (FS) - ie, self-restricted diet, reluctance to try new foods - in children with autism spectrum disorder (ASD) ascertained from a general outpatient autism clinic. STUDY DESIGN: A multidisciplinary team (pediatric nurse practitioner, psychologist and dietitian) assessed medical and psychosocial histories and dietary habits in 103 children with ASD (mean age = 5.8 ± 2.2 years; range 2-10). Parents rated child mealtime behavior on the Brief Autism Mealtime Behavior Inventory (BAMBI) and disruptive behavior on the Aberrant Behavior Checklist (ABC). Height and weight measurements were collected. Children were classified as FS or no FS based on parent reported intake and mealtime behavior. A 24-hour dietary recall was used to record intake percentages < 80%. Logistic regression and multivariable modeling were used to evaluate clinical correlates with FS. RESULTS: Of 103 children, 45.6% (n = 47) were classified as FS; 54.4% (n = 56) no FS. After adjusting for potential confounders, the odds of FS increased by 1.91 (95% CI: 1.38, 2.64, P < .001) for every half-SD increase in BAMBI total score and by 1.35 (95% CI: 1.05, 1.74, P = .020) for every half-SD increase in ABC Hyperactivity/Noncompliance. No group differences in anthropometrics or nutritional intake were identified. CONCLUSIONS: Food selectivity (FS) in children with ASD was strongly associated with greater severity of disruptive mealtime and hyperactivity/noncompliance behaviors. FS was not associated with anthropometrics or nutritional intake.


Subject(s)
Autism Spectrum Disorder , Humans , Autism Spectrum Disorder/psychology , Autism Spectrum Disorder/epidemiology , Male , Female , Child , Child, Preschool , Prevalence , Feeding Behavior , Food Preferences
2.
J Pediatr ; 223: 73-80.e2, 2020 08.
Article in English | MEDLINE | ID: mdl-32532645

ABSTRACT

OBJECTIVE: To assess characteristics and outcomes of young children receiving intensive multidisciplinary intervention for chronic food refusal and feeding tube dependence. STUDY DESIGN: We conducted a retrospective study of consecutive patients (birth to age 21 years) admitted to an intensive multidisciplinary intervention program over a 5-year period (June 2014-June 2019). Inclusion criteria required dependence on enteral feeding, inadequate oral intake, and medical stability to permit tube weaning. Treatment combined behavioral intervention and parent training with nutrition therapy, oral-motor therapy, and medical oversight. Data extraction followed a systematic protocol; outcomes included anthropometric measures, changes in oral intake, and percentage of patients fully weaned from tube feeding. RESULTS: Of 229 patients admitted during the 5-year period, 83 met the entry criteria; 81 completed intervention (98%) and provided outcome data (46 males, 35 females; age range, 10-230 months). All patients had complex medical, behavioral, and/or developmental histories with longstanding feeding problems (median duration, 33 months). At discharge, oral intake improved by 70.5%, and 27 patients (33%) completely weaned from tube feeding. Weight gain (mean, 0.39 ± 1 kg) was observed. Treatment gains continued following discharge, with 58 patients (72%) weaned from tube feeding at follow-up. CONCLUSIONS: Our findings support the effectiveness of our intensive multidisciplinary intervention model in promoting oral intake and reducing dependence on tube feeding in young children with chronic food refusal. Further research on the generalizability of this intensive multidisciplinary intervention approach to other specialized treatment settings and/or feeding/eating disorder subtypes is warranted.


Subject(s)
Behavior Therapy/methods , Enteral Nutrition/adverse effects , Feeding Behavior/psychology , Feeding and Eating Disorders of Childhood/therapy , Child , Child, Preschool , Enteral Nutrition/psychology , Feeding and Eating Disorders of Childhood/psychology , Female , Humans , Male , Parents/psychology , Retrospective Studies
3.
J Pediatr ; 211: 185-192.e1, 2019 08.
Article in English | MEDLINE | ID: mdl-31056202

ABSTRACT

OBJECTIVE: To assess the feasibility and initial efficacy of a structured parent training program for children with autism spectrum disorder and moderate food selectivity. STUDY DESIGN: This 16-week randomized trial compared the Managing Eating Aversions and Limited variety (MEAL) Plan with parent education. MEAL Plan (10 core and 3 booster sessions) provided parents with nutrition education and strategies to structure meals and expand the child's diet. Parent education (10 sessions) provided information about autism without guidance on nutrition, meal structure, or diet. In addition to feasibility outcomes, primary efficacy outcomes included the Clinical Global Impression - Improvement scale and the Brief Autism Mealtime Behaviors Inventory. Grams consumed during a meal observation served as a secondary outcome. RESULTS: There were 38 eligible children (19 per group, 32 males). For MEAL Plan, attrition was <10% and attendance >80%. Therapists achieved >90% fidelity. At week 16, positive response rates on the Clinical Global Impression - Improvement scale were 47.4% for the MEAL Plan and 5.3% for parent education (P < .05). The adjusted mean difference (SE) on Brief Autism Mealtime Behaviors Inventory at week 16 was 7.04 (2.71) points (P = .01) in favor of MEAL Plan. For grams consumed, the adjusted standard mean difference (SE) was 30.76 (6.75), also in favor of MEAL Plan (P = .001). CONCLUSIONS: The MEAL Plan seems to be feasible, and preliminary efficacy results are encouraging. If further study replicates these results, the MEAL Plan could expand treatment options for children with autism spectrum disorder and moderate food selectivity. TRIAL REGISTRATION: Clinicaltrials.gov: NCT02712281.


Subject(s)
Autism Spectrum Disorder/psychology , Feeding Behavior/psychology , Feeding and Eating Disorders of Childhood/rehabilitation , Food Preferences/psychology , Parents/education , Child , Child, Preschool , Female , Humans , Male
4.
J Pediatr ; 181: 116-124.e4, 2017 02.
Article in English | MEDLINE | ID: mdl-27843007

ABSTRACT

OBJECTIVE: To assess models of care and conduct a meta-analysis of program outcomes for children receiving intensive, multidisciplinary intervention for pediatric feeding disorders. STUDY DESIGN: We searched Medline, PsycINFO, and PubMed databases (2000-2015) in peer-reviewed journals for studies that examined the treatment of children with chronic food refusal receiving intervention at day treatment or inpatient hospital programs. Inclusion criteria required the presentation of quantitative data on food consumption, feeding behavior, and/or growth status before and after intervention. Effect size estimates were calculated based on a meta-analysis of proportions. RESULTS: The systematic search yielded 11 studies involving 593 patients. Nine articles presented outcomes based on retrospective (nonrandomized) chart reviews; 2 studies involved randomized controlled trials. All samples involved children with complex medical and/or developmental histories who displayed persistent feeding concerns requiring formula supplementation. Behavioral intervention and tube weaning represented the most common treatment approaches. Core disciplines overseeing care included psychology, nutrition, medicine, and speech-language pathology/occupational therapy. The overall effect size for percentage of patients successfully weaned from tube feeding was 71% (95% CI 54%-83%). Treatment gains endured following discharge, with 80% of patients (95% CI 66%-89%) weaned from tube feeding at last follow-up. Treatment also was associated with increased oral intake, improved mealtime behaviors, and reduced parenting stress. CONCLUSIONS: Results indicate intensive, multidisciplinary treatment holds benefits for children with severe feeding difficulties. Future research must address key methodological limitations to the extant literature, including improved measurement, more comprehensive case definitions, and standardization/examination of treatment approach.


Subject(s)
Feeding and Eating Disorders/diagnosis , Feeding and Eating Disorders/therapy , Nutritional Requirements , Nutritional Status , Child , Child, Preschool , Female , Humans , Interdisciplinary Communication , Male , Prognosis , Randomized Controlled Trials as Topic , Retrospective Studies , Risk Assessment , Severity of Illness Index , Standard of Care
5.
J Transcult Nurs ; 24(1): 68-77, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22913985

ABSTRACT

PURPOSE: This study describes causal beliefs about depression among Dominican, Colombian, and Ecuadorian immigrants. The authors describe participants' narratives about how particular supernatural or religious beliefs may contribute to or alleviate depression. METHOD: Latino primary care patients (n = 177) were interviewed with the Beliefs About Causes of Depression Scale, a list of 35 items rated from not at all important to extremely important. Participants had the option of expanding on responses using an informal conversational approach. Underlying themes of these explanatory comments were derived from narrative and content analysis. RESULTS: Major themes that emerged were Psychosocial and Religious and Supernatural causal beliefs. A third theme emerged that represented the integration of these categories in the context of the immigrant experience. DISCUSSION AND CONCLUSIONS: This article adds to the understanding of cross-cultural beliefs about depression. Psychosocial stressors related to the immigrant experience and adverse life events were highly endorsed, but the meaning of these stressors was construed in terms of religious and cultural values. To provide culturally appropriate services, nurses should be aware of and discuss the patient's belief systems, illness interpretations, and expectations of treatment.


Subject(s)
Culture , Depressive Disorder/ethnology , Emigrants and Immigrants/psychology , Health Knowledge, Attitudes, Practice/ethnology , Hispanic or Latino/psychology , Adolescent , Adult , Colombia/ethnology , Depressive Disorder/etiology , Depressive Disorder/therapy , Dominican Republic/ethnology , Ecuador/ethnology , Female , Humans , Life Change Events , Male , Middle Aged , Religion , Socioeconomic Factors , Young Adult
6.
Braz J Psychiatry ; 28 Suppl 1: S39-46, 2006 May.
Article in Portuguese | MEDLINE | ID: mdl-16791391

ABSTRACT

Autistic disorder and the group of related conditions defined as pervasive developmental disorders are chronic neurodevelopmental disorders starting in early childhood and affecting a significant number of children and families. Although the causes and much of the pathophysiology of the disorder remain unknown, in recent years a number of available medication treatments have been identified as holding promise in alleviating some of the most disabling maladaptive behaviors, associated with pervasive developmental disorders. However these treatments do not address the core symptoms of the disease and oftentimes their side effects outweigh their benefits. Therefore there is substantial need for new medications that are safer and more effective in addressing the behavior symptoms of autism. The aim of this review is to highlight the available current pharmacotherapies and those emerging treatments with potential to enhance the treatment options of patients with pervasive developmental disorders.


Subject(s)
Antidepressive Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Autistic Disorder/drug therapy , Clinical Trials as Topic , Clozapine/therapeutic use , Humans , Placebos , Risperidone/therapeutic use
7.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; Braz. J. Psychiatry (São Paulo, 1999, Impr.);28(supl.1): s39-s46, maio 2006. tab, graf
Article in Portuguese | LILACS | ID: lil-429858

ABSTRACT

O transtorno autista e o grupo de condições relacionadas definidas como transtornos invasivos do desenvolvimento são transtornos de neurodesenvolvimento crônicos que começam na infância precoce e afetam um número significativo de crianças e suas famílias. Ainda que as causas e muito da fisiopatologia do transtorno sejam desconhecidas, em anos recentes, vários tratamentos medicamentosos disponíveis têm sido identificados como contendo a promessa de aliviar alguns dos comportamentos mal-adaptativos mais comprometedores associados aos transtornos invasivos do desenvolvimento. No entanto, esses tratamentos não enfocam os sintomas nucleares da enfermidade e, geralmente, seus efeitos colaterais excedem os benefícios. Portanto, há uma necessidade substancial de novas medicações que sejam mais seguras e mais eficazes em tratar os sintomas comportamentais do autismo. O objetivo desta revisão é o de destacar as farmacoterapias correntes disponíveis e aquelas emergentes e que tenham potencial de melhorar as opções de tratamento de pacientes com transtornos invasivos do desenvolvimento.


Subject(s)
Humans , Antidepressive Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Autistic Disorder/drug therapy , Clinical Trials as Topic , Clozapine/therapeutic use , Placebos , Risperidone/therapeutic use
12.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; Braz. J. Psychiatry (São Paulo, 1999, Impr.);4(22): 189-193, dez. 2000.
Article | Index Psychology - journals | ID: psi-15958

ABSTRACT

Os transtornos coreicos sao relativamente comuns durante a infancia. Os automatismos apresentam graus variaveis, de leve a grave, e flutuam ao longo do tempo. Alem disso, na maioria dos casos, os automatismos tendem a diminuir em numero e frequencia no inicio da vida adulta. Dada a gravidade variavel e sua historia natural, muitas vezes nao e necessario tratar os automatismos. O tratamento medicamentoso esta indicado quando as manifestacoes sao frequentes, vigorosas e interferem com a vida diaria. Varios medicamentos tem sido usados no tratamento de automatismos, mas apenas alguns deles vem sendo estudados a fundo. O artigo revisa variedade de medicamentos que vem sendo usados no tratamento dos automatismos e proporciona informacoes praticas para o tratamento clinico de criancas e adolescentes com transtornos coreicos.


Subject(s)
Pediatrics , Child , Tics , Therapeutics , Tourette Syndrome , Antipsychotic Agents , Child , Tics , Therapeutics
SELECTION OF CITATIONS
SEARCH DETAIL